---
document_datetime: 2023-09-21 19:11:47
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/xeloda-epar-all-authorised-presentations_en.pdf
document_name: xeloda-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7124314
conversion_datetime: 2025-12-28 02:18:32.504229
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU-nummer       | Invented Name   | Strength   | Pharmaceutical Form   | Route of   | Packaging         | Package size   |
|-----------------|-----------------|------------|-----------------------|------------|-------------------|----------------|
| EU/1/00/163/001 | Xeloda          | 150 mg     | Film coated tablet    | Oral Use   | Blister(PVC/PVDC) | 60 tablets     |
| EU/1/00/163/002 | Xeloda          | 500 mg     | Film coated tablet    | Oral Use   | Blister(PVC/PVDC) | 120 tablets    |